Skip to main content
TRAX logo

TRAX · First Tracks Biotherapeutics, Inc. · Executive Compensation

Track TRAX — free
$44.79 +0.29 (+0.65%)
Market Cap
$1.87B
Shares
42.02M
Volume · Nov 19 98.53K Avg daily vol (3M) 827.63K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Ajim Tamboli Appointed 2026-04-20

Leadership

Key facts CIK 2091349 CUSIP 337185102 13F (30d) 178 filings 175 filers Visit website Investor relations